These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34582650)

  • 21. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HES1 as an independent prognostic marker in esophageal squamous cell carcinoma.
    Taleb S; Abbaszadegan MR; Moghbeli M; Roudbari NH; Forghanifard MM
    J Gastrointest Cancer; 2014 Dec; 45(4):466-71. PubMed ID: 25139105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.
    Casado E; Garcia VM; Sánchez JJ; Gómez Del Pulgar MT; Feliu J; Maurel J; Castelo B; Moreno Rubio J; López RA; García-Cabezas MÁ; Burgos E; de Castro J; Belda-Iniesta C; López-Gómez M; Gómez-Raposo C; Zambrana F; Sereno M; Fernández-Martos C; Vázquez P; Lacal JC; González-Barón M; Cejas P
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1151-8. PubMed ID: 22516806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
    Rot S; Kaune T; Taubert H; Greither T; Kotrba J; Güttler A; Wichmann H; Bilkenroth U; Wienke A; Al-Nawas B; Bache M; Vordermark D; Wickenhauser C; Bethmann D; Eckert AW; Kappler M
    BMC Cancer; 2019 Feb; 19(1):155. PubMed ID: 30770730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.
    Peignon G; Durand A; Cacheux W; Ayrault O; Terris B; Laurent-Puig P; Shroyer NF; Van Seuningen I; Honjo T; Perret C; Romagnolo B
    Gut; 2011 Feb; 60(2):166-76. PubMed ID: 21205878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ validation of an intestinal stem cell signature in colorectal cancer.
    Ziskin JL; Dunlap D; Yaylaoglu M; Fodor IK; Forrest WF; Patel R; Ge N; Hutchins GG; Pine JK; Quirke P; Koeppen H; Jubb AM
    Gut; 2013 Jul; 62(7):1012-23. PubMed ID: 22637696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
    Voogt ELK; Schaap DP; van den Berg K; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Willems J; Cnossen JS; Peulen HMU; Nederend J; van Lijnschoten G; Burger JWA; Rutten HJT
    Eur J Surg Oncol; 2021 Sep; 47(9):2429-2435. PubMed ID: 34030921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Hes1 expression and resultant Ascl1 suppression regulate quiescent vs. active neural stem cells in the adult mouse brain.
    Sueda R; Imayoshi I; Harima Y; Kageyama R
    Genes Dev; 2019 May; 33(9-10):511-523. PubMed ID: 30862661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 31. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
    Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
    Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
    Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
    BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.
    Chen WW; Wang F; Zhang DS; Luo HY; Wang ZQ; Wang FH; Qiu MZ; Ren C; Wei XL; Wu WJ; Li YH; Xu RH
    BMC Cancer; 2014 Mar; 14():222. PubMed ID: 24666414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Okugawa Y; Fujikawa H; Matsushita K; Uchida K; Inoue Y; Kusunoki M
    Surg Today; 2012 May; 42(5):460-9. PubMed ID: 22072148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study.
    Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Kishikawa J; Ishii H; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Oba K; Ishihara S
    Int J Clin Oncol; 2022 Jan; 27(1):141-153. PubMed ID: 34741193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative endoscopic tattooing technique improved lymph node retrieval in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    Chen YT; Wang JY; Wang JW; Chai CY
    J Clin Pathol; 2020 May; 73(5):267-272. PubMed ID: 31690565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.